AR004178A1 - PROCEDURE FOR THE FORMULATION OF A PHARMACY, A PHARMACEUTICAL COMPOSITION OBTAINABLE THROUGH THIS PROCEDURE AND THE USE OF THE SAME. - Google Patents
PROCEDURE FOR THE FORMULATION OF A PHARMACY, A PHARMACEUTICAL COMPOSITION OBTAINABLE THROUGH THIS PROCEDURE AND THE USE OF THE SAME.Info
- Publication number
- AR004178A1 AR004178A1 ARP960103748A AR10374896A AR004178A1 AR 004178 A1 AR004178 A1 AR 004178A1 AR P960103748 A ARP960103748 A AR P960103748A AR 10374896 A AR10374896 A AR 10374896A AR 004178 A1 AR004178 A1 AR 004178A1
- Authority
- AR
- Argentina
- Prior art keywords
- procedure
- formulation
- pharmacy
- pharmaceutical composition
- same
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/439—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Abstract
Un procedimiento para formulación de fármacos, que comprende mezclar partículas de un vehículo con una solución de un fármaco monohidrocloruro de[R-(Z)]-alfa-(metoximiimino)-alfa-(1-azabiciclo[2.2.2]-oct-3-il)acetonitrilo, en agua en unacan tidad de 1-3% en peso de solución a mezcla total,composiciones farmacéuticas utilizadas en él y el uso de dichas composiciones farmacéuticas en el tratamiento y/o profilaxis de la demencia.A method for drug formulation, which comprises mixing particles of a carrier with a solution of a [R- (Z)] - alpha- (methoxyimino) -alpha- (1-azabicyclo [2.2.2] -oct- 3-yl) acetonitrile, in water in an amount of 1-3% by weight of solution to total mixture, pharmaceutical compositions used therein and the use of said pharmaceutical compositions in the treatment and / or prophylaxis of dementia.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9515624.6A GB9515624D0 (en) | 1995-07-29 | 1995-07-29 | Novel process |
| GBGB9606684.0A GB9606684D0 (en) | 1996-03-29 | 1996-03-29 | Novel process |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR004178A1 true AR004178A1 (en) | 1998-11-04 |
Family
ID=26307485
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP960103748A AR004178A1 (en) | 1995-07-29 | 1996-07-25 | PROCEDURE FOR THE FORMULATION OF A PHARMACY, A PHARMACEUTICAL COMPOSITION OBTAINABLE THROUGH THIS PROCEDURE AND THE USE OF THE SAME. |
Country Status (25)
| Country | Link |
|---|---|
| EP (1) | EP0841902A2 (en) |
| JP (1) | JPH11510493A (en) |
| KR (1) | KR19990035972A (en) |
| CN (1) | CN1196677A (en) |
| AP (1) | AP858A (en) |
| AR (1) | AR004178A1 (en) |
| AU (1) | AU716961B2 (en) |
| BG (1) | BG102266A (en) |
| BR (1) | BR9609804A (en) |
| CA (1) | CA2228048A1 (en) |
| CZ (1) | CZ24798A3 (en) |
| DZ (1) | DZ2077A1 (en) |
| EA (2) | EA000740B1 (en) |
| HU (1) | HUP9900521A3 (en) |
| IL (1) | IL122897A0 (en) |
| MA (1) | MA23953A1 (en) |
| MX (1) | MX9800809A (en) |
| NO (1) | NO980384L (en) |
| NZ (1) | NZ315632A (en) |
| OA (1) | OA10659A (en) |
| PL (1) | PL325242A1 (en) |
| SK (1) | SK11098A3 (en) |
| TR (1) | TR199800156T1 (en) |
| UY (1) | UY24297A1 (en) |
| WO (1) | WO1997004750A2 (en) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9619074D0 (en) * | 1996-09-12 | 1996-10-23 | Smithkline Beecham Plc | Composition |
| IL138192A0 (en) * | 1998-03-11 | 2001-11-25 | Smithkline Beecham Plc | Controlled release oral dosage forms |
| FR2796840B1 (en) * | 1999-07-26 | 2003-06-20 | Ethypharm Lab Prod Ethiques | LOW-DOSE TABLETS AND METHOD OF PREPARATION |
| KR100899032B1 (en) | 2000-12-14 | 2009-05-21 | 오르토-맥네일 파마슈티칼, 인코퍼레이티드 | Steroid hormone products comprising a stabilizing agent in non-crystalline form |
| WO2005097076A2 (en) * | 2004-04-09 | 2005-10-20 | Smithkline Beecham Corporation | Low dose pharmaceutical products |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4489026A (en) * | 1982-09-07 | 1984-12-18 | The Upjohn Company | Process for preparing solid unit dosage forms of ultra-low dose drugs |
| JPS5970614A (en) * | 1982-10-14 | 1984-04-21 | Asahi Chem Ind Co Ltd | Wet solid pharmaceutical preparation of very small amount of main drug |
| US4898736A (en) * | 1988-03-09 | 1990-02-06 | Merck & Co., Inc. | Method for tablet preparation |
| ES2219636T3 (en) * | 1989-04-13 | 2004-12-01 | Beecham Group P.L.C. | NEW COMPOUNDS. |
| ZA939565B (en) * | 1993-12-21 | 1994-08-11 | Applied Analytical Ind Inc | Method for preparing low dose pharmaceutical products. |
-
1996
- 1996-07-25 AR ARP960103748A patent/AR004178A1/en not_active Application Discontinuation
- 1996-07-26 UY UY24297A patent/UY24297A1/en not_active IP Right Cessation
- 1996-07-26 MA MA24329A patent/MA23953A1/en unknown
- 1996-07-27 DZ DZ960121A patent/DZ2077A1/en active
- 1996-07-29 NZ NZ315632A patent/NZ315632A/en unknown
- 1996-07-29 CN CN96197054A patent/CN1196677A/en active Pending
- 1996-07-29 AP APAP/P/1998/001170A patent/AP858A/en active
- 1996-07-29 IL IL12289796A patent/IL122897A0/en unknown
- 1996-07-29 BR BR9609804A patent/BR9609804A/en not_active Application Discontinuation
- 1996-07-29 KR KR1019980700633A patent/KR19990035972A/en not_active Application Discontinuation
- 1996-07-29 EA EA199800179A patent/EA000740B1/en not_active IP Right Cessation
- 1996-07-29 JP JP9507243A patent/JPH11510493A/en active Pending
- 1996-07-29 HU HU9900521A patent/HUP9900521A3/en unknown
- 1996-07-29 AU AU67384/96A patent/AU716961B2/en not_active Ceased
- 1996-07-29 PL PL96325242A patent/PL325242A1/en unknown
- 1996-07-29 EA EA199901055A patent/EA199901055A1/en unknown
- 1996-07-29 TR TR1998/00156T patent/TR199800156T1/en unknown
- 1996-07-29 EP EP96927621A patent/EP0841902A2/en not_active Withdrawn
- 1996-07-29 CZ CZ98247A patent/CZ24798A3/en unknown
- 1996-07-29 WO PCT/EP1996/003326 patent/WO1997004750A2/en not_active Application Discontinuation
- 1996-07-29 CA CA002228048A patent/CA2228048A1/en not_active Abandoned
- 1996-07-29 MX MX9800809A patent/MX9800809A/en unknown
- 1996-07-29 SK SK110-98A patent/SK11098A3/en unknown
-
1998
- 1998-01-28 OA OA9800013A patent/OA10659A/en unknown
- 1998-01-28 NO NO980384A patent/NO980384L/en unknown
- 1998-02-20 BG BG102266A patent/BG102266A/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| NO980384D0 (en) | 1998-01-28 |
| MX9800809A (en) | 1998-04-30 |
| CN1196677A (en) | 1998-10-21 |
| NO980384L (en) | 1998-03-26 |
| OA10659A (en) | 2002-09-18 |
| KR19990035972A (en) | 1999-05-25 |
| AU716961B2 (en) | 2000-03-09 |
| MA23953A1 (en) | 1997-04-01 |
| SK11098A3 (en) | 1998-07-08 |
| JPH11510493A (en) | 1999-09-14 |
| CA2228048A1 (en) | 1997-02-13 |
| BG102266A (en) | 1998-10-30 |
| UY24297A1 (en) | 1997-01-23 |
| EA199800179A1 (en) | 1998-10-29 |
| HUP9900521A2 (en) | 1999-06-28 |
| AP858A (en) | 2000-07-12 |
| BR9609804A (en) | 1999-07-06 |
| WO1997004750A2 (en) | 1997-02-13 |
| AU6738496A (en) | 1997-02-26 |
| EA199901055A1 (en) | 2000-06-26 |
| CZ24798A3 (en) | 1998-06-17 |
| TR199800156T1 (en) | 1998-04-21 |
| EP0841902A2 (en) | 1998-05-20 |
| DZ2077A1 (en) | 2002-07-22 |
| HUP9900521A3 (en) | 2001-04-28 |
| IL122897A0 (en) | 1998-08-16 |
| AP9801170A0 (en) | 1998-01-31 |
| NZ315632A (en) | 1999-11-29 |
| WO1997004750A3 (en) | 1997-03-27 |
| PL325242A1 (en) | 1998-07-06 |
| EA000740B1 (en) | 2000-02-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PT101061A (en) | PHARMACEUTICAL COMPOSITIONS CONTAINING ANAGOLS OF CAMPTOTECIN AND A PLATINUM COORDINATION COMPOUND AND ITS USE IN THE INHIBITION OF TUMOR CELL GROWTH | |
| EE03177B1 (en) | Heterobicyclic compounds, methods for their preparation and pharmaceutical compositions containing said compounds | |
| MX9405383A (en) | IMIDAZO (4,5-C) PIRIDIN-4-AMINAS. | |
| MX9700223A (en) | Pharmaceutical composition for the controlled release of moguisteine in a liquid suspension. | |
| IL80149A (en) | Pharmaceutical compositions containing toluidide derivatives against graft-versus-host diseases and autoimmune diseases | |
| MX9202407A (en) | PHARMACEUTICAL COMPOSITION CONTAINING AN ALYLAMINE COMPOUND AS THE ACTIVE AGENT AND PROCESS FOR ITS PREPARATION. | |
| ZA921875B (en) | New esters of bi- and tricyclic amino alcohols, their preparation and their use in pharmaceutical compositions | |
| PT991653E (en) | NEW COMPOUNDS | |
| IT1199962B (en) | CYCLOSPORINS, PROCESSES FOR THEIR PREPARATION, PHARMACEUTICAL USE OF THE SAME AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | |
| MX9300407A (en) | AZABICICLIC DERIVATIVES USED IN THE MANUFACTURE OF MEDICINES, CONTAINING COMPOSITIONS AND PROCEDURE FOR THE PREPARATION. | |
| ITMO920035A1 (en) | DROPPER BOTTLE PARTICULARLY FOR PHARMACEUTICAL PRODUCTS ACTIVATED FOR MIXING USE | |
| PT86186A (en) | Process for the preparation of benzimidazol derivatives and of pharmaceutical compositions containing the same | |
| HUP0103203A2 (en) | Azaadamantane derivatives and pharmaceutical compositions thereof | |
| ES2134801T3 (en) | CRYSTAL TIAGABINE HYDROCHLORIDE MONOHYDRATE, ITS PREPARATION AND USE. | |
| HU9400430D0 (en) | New pyrazine derivatives, their preparation and pharmaceutical compositions containing them | |
| ES2111163T3 (en) | USE OF PHOSPHONATES FOR THE TREATMENT OF OSTEOPOROSIS. | |
| MX9401080A (en) | HETEROAROMATIC COMPOUNDS. | |
| AR004178A1 (en) | PROCEDURE FOR THE FORMULATION OF A PHARMACY, A PHARMACEUTICAL COMPOSITION OBTAINABLE THROUGH THIS PROCEDURE AND THE USE OF THE SAME. | |
| IL105607A0 (en) | Heteroatoms-containing tricyclic compounds,their preparation and pharmaceutical compositions containing them | |
| IT1237474B (en) | TRIPEPTIDIC COMPOUNDS AND THEIR PHARMACEUTICAL USE AS IMMUNO-MODULATORS | |
| PA8496701A1 (en) | POLYMORPHES OF A CRYSTALLINE DICLORHYDRATE OF AZOBICICLO [2.2.2] OCT- 3 - ILAMINE AND ITS PHARMACEUTICAL COMPOSITIONS | |
| IL67925A0 (en) | Laevorotatory isomer of mequitazine,its preparation and pharmaceutical compositions containing it | |
| BR9710038A (en) | New radiopharmaceutical compositions and matrices and their uses. | |
| FI822671L (en) | AMINOGLYCOSIDE DERIVATIVES, PHARMACEUTICAL COMPOSITION FOR FRAMSTAELLNING AV DEM, PHARMACEUTICAL COMPOSITION INNEHAOLLANDE DEM | |
| IL91813A0 (en) | Pharmaceutical compositions containing stable oxapenem-3-carboxylic acids and their preparation |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA | Abandonment or withdrawal |